ALK inhibitors (Cephalon)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameALK inhibitors (Cephalon)
Drug Alias NameAlk inhibitors (Cephalon)CEP-18050
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsLymphoma, Large-Cell, Anaplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCephalon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCephalon Inc
Active IndicationsN/A
Inactive IndicationsLymphoma, Large-Cell, Anaplastic

Other Information

ATC CodeN/A
Related LinksN/A